For the Inventor, By the Inventor

Enter assignee name

Washington, DC, United States of America

Vanda Pharmaceuticals Inc.

USPTO Granted Patents = 108

CIPO Patents = 7

EPO Patents = 41

Trademarks = 19

Forward Citations = 335

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Mihael Hristos Polymeropoulos (72 out of 77 patents)

Louis William Licamele (43 out of 43 patents)

Marlene Michelle Dressman (30 out of 30 patents)

4. Christian Lavedan (26 out of 26 patents)

5. Deepak Phadke (18 out of 19 patents)

6. John Joseph Feeney (15 out of 16 patents)

7. Simona Volpi (15 out of 15 patents)

8. Curt Douglas Wolfgang (13 out of 18 patents)

9. Paolo Baroldi (9 out of 9 patents)

10. Natalie M Platt (8 out of 8 patents)

11. Ravi K Pandrapragada (8 out of 8 patents)

12. Sandra Smieszek (6 out of 6 patents)

13. Gunther Birznieks (4 out of 4 patents)

14. Kendra Tomino Mack (3 out of 3 patents)

15. Callie Michelle Heaton (3 out of 3 patents)

Core Competencies:

Milsaperidone

Tasimelteon Formulations

Cognition Enhancement

Multiple Sclerosis Treatment

Circadian Rhythm Disorders

S1P1 Receptor Agonist

Schizophrenia Treatment

Atopic Dermatitis

Cancer Treatment

Genetic Markers

Liquid Pharmaceutical Formulations

Tradipitant

108 patents: Sort by Forward Citations

1. 12502379 - Ponesimod for avoiding worsening of fatigue-related symptoms in multiple sclerosis patients (2025-12-23),

2. 12478619 - Method of treatment with milsaperidone (2025-11-25),

3. 12447141 - Liquid tasimelteon formulations and methods of use thereof (2025-10-21),

4. 12440470 - Liquid tasimelteon formulations and methods of use thereof (2025-10-14),

5. 12427132 - Method of improving sleep (2025-09-30),

6. 12419869 - Methods of treating multiple sclerosis (2025-09-23),

7. 12409167 - Pharmaceutical combination comprising a selective S1Preceptor agonist (2025-09-09),

8. 12403134 - Method for improving or enhancing cognition (2025-09-02),

9. 12357616 - Methods of treating multiple sclerosis (2025-07-15),

10. 12336980 - Dosing regimen for a selective S1P1 receptor agonist (2025-06-24),

11. 12318375 - Method of treatment with tradipitant (2025-06-03),

12. 12304896 - Highly purified pharmaceutical grade tasimelteon (2025-05-20),

13. 12201604 - Treatment of circadian rhythm disorders (2025-01-21),

14. 12201583 - Pharmaceutical dosage system (2025-01-21),

15. 12146185 - Genetic markers for enhancing efficacy of antipsychotic treatment with iloperidone (2024-11-19),

Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs. With a diverse portfolio of products and a commitment to advancing scientific research, Vanda Pharmaceuticals aims to improve the lives of patients suffering from central nervous system disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

108 Patents

#17 in Washington, DC

#17 in District of Columbia

#3,407 in US

#7,068 in the World

Washington, DC, United States of America

Vanda Pharmaceuticals Inc.

Forward Citations = 335

42 inventors:

Mihael Hristos Polymeropoulos (72 out of 77 patents)

Louis William Licamele (43 out of 43 patents)

Marlene Michelle Dressman (30 out of 30 patents)

4. Christian Lavedan (26 out of 26 patents)

5. Deepak Phadke (18 out of 19 patents)

Please report any incorrect information to support@idiyas.com

Loading…